J.R. Andersen - Concepedia

Author

J.R. Andersen

Also Known As

Andersen, Jeppe Ragnar, J R Andersen, J. Andersen, J. Ragnar Andersen, J.R. Andersen, Jeppe R Andersen, Jeppe R. Andersen, Jeppe Ragnar Andersen

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Nordic Bioscience (Denmark)University of Copenhagen Center for Clinical & Basic Research Merck (Germany)Herlev Hospital

About

J.R. Andersen is an author at Nordic Bioscience (Denmark) specializing in medicine, orthopaedics, and osteoarthritis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	487
2	Health Sciences	3	3	103
3	Public Health	2	2	45
4	Applied Physiology	2	2	30
5	Biostatistics	1	1	61

J.R. Andersen

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Effect of Intra-Articular Sprifermin vs Placebo on Femorotibial Joint Cartilage Thickness in Patients With Osteoarthritis Marc C. Hochberg, Ali Guermazi, Hans Guehring, JAMA	2019	317
Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials M.A. Karsdal, I. Byrjalsen, Peter Alexandersen, Osteoarthritis and Cartilage Symptomatic Knee OsteoarthritisOsteoarthritisMedicineOrthopaedic SurgeryOral Salmon Calcitonin	2015	132
Long-term structural and symptomatic effects of intra-articular sprifermin in patients with knee osteoarthritis: 5-year results from the FORWARD study F. Eckstein, Marc C. Hochberg, Hans Guehring, Annals of the Rheumatic Diseases	2021	124
Randomised study of the influence of non-steroidal anti-inflammatory drugs on the treatment of peptic ulcer in patients with rheumatic disease. Claus Manniche, A Malchow-Møller, J.R. Andersen, Gut Ulcer TreatmentGastroenterologyPharmacotherapySurgeryNon-steroidal Anti-inflammatory Drugs	1987	89
A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D Kim Henriksen, I. Byrjalsen, J.R. Andersen, Bone Bone DiseaseNutritionBone HealthClinical NutritionOral Salmon Calcitonin	2016	73
OA phenotypes, rather than disease stage, drive structural progression – identification of structural progressors from 2 phase III randomized clinical studies with symptomatic knee OA M.A. Karsdal, Asger Reinstrup Bihlet, I. Byrjalsen, Osteoarthritis and Cartilage Musculoskeletal ResearchPhase IiiCartilage DegenerationOsteoarthritisKnee Injuries	2015	61
Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1–31)NH2] in postmenopausal women with osteoporosis Kim Henriksen, J.R. Andersen, B.J. Riis, Bone Pharmacokinetic ProfileMedicineParathyroid HormoneGynecologyMenopause	2012	53
Associations between biomarkers of bone and cartilage turnover, gender, pain categories and radiographic severity in knee osteoarthritis Asger Reinstrup Bihlet, I. Byrjalsen, Anne‐Christine Bay‐Jensen, Arthritis Research & Therapy	2019	53
Impact of source data verification on data quality in clinical trials: an empirical <i>post hoc</i> analysis of three phase 3 randomized clinical trials J.R. Andersen, I. Byrjalsen, Asger Reinstrup Bihlet, British Journal of Clinical Pharmacology	2014	48
Serum C-reactive protein metabolite (CRPM) is associated with incidence of contralateral knee osteoarthritis Anne‐Christine Bay‐Jensen, Asger Reinstrup Bihlet, I. Byrjalsen, Scientific Reports	2021	33

Page 1